Health TrialsbyHealthPanel

"Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"

ConditionLAZMAR Scoring , Hysteroscopic Myomectomy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorAin Shams University

About this trial

This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women aged 18-45 years

Type 0,1,2 Fibroids according to Figo classification.

Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss.

Fibroids size ≤ 5 cm in diameter

Disqualifiers

Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection)

Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis).

Cases requiring concurrent procedures (e.g., Laparoscopic surgeries).

Fibroid Size>5 cm.

Trial population

Women undergoing hysteroscopic myomectomy for symptomatic uterine fibroids.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Hysteroscopic Myomectomy

    Procedure/Surgery

    Hysteroscopic myomectomy is a minimally invasive surgical procedure used to remove fibroids that are located inside the uterine cavity (submucosal fibroids).

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications.

Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications

Time frame
2 years

Secondary outcomes

1

Postoperative Complications: Including infection, adhesions, volume overload.

Postoperative Complications: Including infection, adhesions, volume overload.

Time frame
2 years
2

Need for Further Interventions: Incidence of additional treatments like hormonal therapy

Need for Further Interventions: Incidence of additional treatments like hormonal therapy

Time frame
2 years

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Ain Shams University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: